MedTrace Logo

Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety

NCT03346239 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2022-02-01

No results posted yet for this study

Summary

The purpose of this study is to determine the clinical efficacy and neuro-cognitive mechanisms of Gaze-Contingent Usic Reward Therapy for social anxiety disorder, compared with treatment with SSRIs or waitlist control.

Conditions

Interventions

BEHAVIORAL

Gaze Contingent Music Reward Therapy

Feedback according to participants' viewing patterns, in order to modify their attention.

DRUG

Escitalopram

10-20 mg of Escitalopram

BEHAVIORAL

Waitlist

Participants will wait for 12 weeks while in touch with the clinic, then receive GC-MRT for 8 weeks.

Sponsors & Collaborators

  • Sheba Medical Center

    collaborator OTHER_GOV

  • Tel-Aviv Sourasky Medical Center

    collaborator OTHER_GOV

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Yair Bar-Haim, PhD · Tel Aviv University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-20
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03346239 on ClinicalTrials.gov